S.A. Enterprises
Madhav Nagar, Nagpur, Maharashtra
GST No. 27ABKFS8971R1ZV
TrustSEAL Verified
Call 0804898841282% Response Rate
SEND EMAIL
Product Details:
| Minimum Order Quantity | 10 Stripe |
| Strength | 200 mg |
| Packaging Type | Stripe |
| Composition | HYDROCHLOROQUINE 200 MG |
| Packaging Size | 10*10 Tablets |
| Brand | HSQUIN |
| Manufacturer | JOHN LEE |
| Form | Tablet |
| Usage / Application | Hospital |
| Manufacture By | JOHN LEE |
| Manufactured By | JOHN LEE |
| Country of Origin | Made in India |
Hydroxychloroquine is a medication that has been primarily used to treat and prevent malaria. It's also used in the management of certain autoimmune conditions, particularly systemic lupus erythematosus and rheumatoid arthritis. Here's a description of Hydroxychloroquine 200 mg and its top three categories of use:
1. Antimalarial: Hydroxychloroquine, as well as its closely related compound chloroquine, is primarily known for its role as an antimalarial medication. It is used to treat and prevent malaria, a mosquito-borne infectious disease caused by the Plasmodium parasite. Hydroxychloroquine works by interfering with the parasite's ability to survive and reproduce within the human body. It's often used in regions where malaria is endemic to reduce the risk of infection in travelers and residents.
2. Autoimmune Disorders (Systemic Lupus Erythematosus and Rheumatoid Arthritis): Hydroxychloroquine is commonly prescribed to manage autoimmune disorders such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). These conditions involve an overactive immune response that can lead to inflammation and damage in various organs and tissues. Hydroxychloroquine helps to suppress the immune response and reduce inflammation, thus alleviating symptoms and preventing disease flares in individuals with SLE and RA.
3. Off-Label Uses (COVID-19 and Other Conditions): In addition to its established uses, Hydroxychloroquine gained significant attention during the COVID-19 pandemic. There were debates and studies exploring its potential efficacy in treating COVID-19, caused by the novel coronavirus. However, the effectiveness of Hydroxychloroquine in treating COVID-19 remains controversial, and its use for this purpose is not universally recommended by health authorities. Outside of malaria and autoimmune disorders, Hydroxychloroquine has also been investigated for off-label uses, including various skin conditions and certain other autoimmune diseases.
Additional Information: